Anna Shcherbina, Russian Federation

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Chief of Immunology
Education: 1986-1992 M.D. Moscow Pirogov Medical University (Moscow) 1997 Ph.D. Research Institute for Pediatric Hematology (Moscow) Postdoctoral Training: 1992-1994 Fellowship in Immunology, Research Institute for Pediatric Hematology, Moscow. 1995- 1998 Research Fellowship, The Center for Blood Research, Harvard Medical School, Boston, MA. Licensure and Certification (latest): 1992 Russian Doctoral Diploma. 2015 Immunologyallergy certification 2016 Pediatrics Certification Current Professional Positions: Deputy director, Institute of Hematology, Immunology and Cellular Technologies, National Medical Research Center of Pediatric Hematology, Oncology, Immunology, Moscow, Russia Educational activity: 1998-current Professor, Dept. of HematologyOncology, Russian Research Medical University, Moscow, Russia. 2015-current Annual International Summer School for PID, Moscow, Russia – Head of the organizing committee. Memberships, Offices and Committee Assignments in Professional Societies: 1994- current Russian Society of Pediatric Allergy and Immunology. 1998-current European Society for Immunodeficiencies (ESID) 2015-current National Association of Experts in Primary Immunodeficiencies (NAEPID), Executive Director Areas of specific expertise: Wiskott-Aldrich syndrome Hematopoietic stem cell transplantation in primary immunodeficiencies Autoinflammatory disorders

Presenter of 1 Presentation

Poster Display Other

CLINICAL FEATURES AND IMMUNOLOGICAL DEFECTS IN A GROUP OF RUSSIAN PATIENTS WITH WHIM SYNDROME.

Lecture Time
10:41 - 10:42
Room
Poster Area
Date
20.09.2019, Friday
Session Time
10:00 - 17:00
Board Number
146
Presentation Topic
Other

Abstract

Background and Aims

WHIM syndrome is a rare primary immunodeficiency that is characterized by neutropenia with myelokathexis, hypogammaglobulinema, susceptibility to human papilloma virus infection. It is caused by autosomal dominant gain-of-function mutations in CXC chemokine receptor 4 (CXCR4).

Methods

We report a group of 7 patients (6 from unrelated families, one family - P3 is a son of P4) 1-40 years (M – 4y) with CXCR4 mutations. The mutations were detected via NGS targeted panel sequencing and/or Sanger’s sequencing.

Results

All patients manifested with neutropenia, myelokathexis and lymphopenia was observed at the onset of the disease. Four of them had the same mutation (p.R334X). Hypogammaglobulinemia was observed in 6 patients where as P2 showed borderline levels. Severe infections (pneumonia and lung abscess) were observed in 2 patients. Skin warts were observed only in adult patient (P4). 4 patients had variable congenital heart defects, three patients had renal abnormalities. 6 patients were treated with prophylactic antimicrobials, IVIG and subcutaneous injections of G-SCF (3 - 10 μg/kg/d). 2 patients underwent HSCT from a 10/10 (P6) and 9/10 (P3) matched unrelated donor, they are currently 5 years and 60 days post-transplant, respectively, with full donor chimerism.

Conclusions

CXCR4 defects need to be considered in patients with chronic neutropenia and congenital anomalies, especially heart and renal defects, despite lack of severe infections and warts. Based on our experience WHIM can be effectively treated with HSCT, though longer follow-up is needed.

Hide

Moderator of 1 Session

Parallel Session
Room
Bozar
Date
20.09.2019, Friday
Session Time
11:00 - 12:40